BACKGROUND: Access to protocols and statistical analysis plans (SAPs) increases the transparency of randomised trial by allowing readers to identify and interpret unplanned changes to study methods, however they are often not made publicly available. We sought to determine how often study investigators would share unavailable documents upon request. METHODS: We used trials from two previously identified cohorts (cohort 1: 101 trials published in high impact factor journals between January and April of 2018; cohort 2: 100 trials published in June 2018 in journals indexed in PubMed) to determine whether study investigators would share unavailable protocols/SAPs upon request. We emailed corresponding authors of trials with no publicly avai...
Background: Little is known about publication agreements between industry and academic investigators...
Introduction: Registration and publication of trial protocols has become increasingly important and ...
Abstract Background Authors of systematic reviews have difficulty obtaining unpublished data for the...
BACKGROUND AND OBJECTIVE: Prespecification of statistical methods in clinical trial protocols and st...
In 2017, JAMA published a statistical analysis plan (SAP) guidance document for randomised clinical ...
OBJECTIVE: Pre-specification of statistical methods in clinical trial protocols and Statistical Anal...
BACKGROUND: Choosing or altering the planned statistical analysis approach after examination of tria...
Objectives To explore the effectiveness of data sharing by randomized controlled trials (RCTs) in jo...
Background Individual patient data (IPD) meta-analysis is considered the “gold standard” for explori...
Background: All clinical research benefits from transparency and validity. Transparency and validity...
This article is distributed under the terms of the Creative Commons Attribution 4.0 International Li...
Abstract Background Recognizing the value of promotin...
BACKGROUND: Publication of complete trial results is essential if people are to be able to make well...
Evidence of unexplained discrepancies between planned and conducted statistical analyses: a review o...
BACKGROUND: Individual patient data (IPD) meta-analysis is considered the "gold standard" for explor...
Background: Little is known about publication agreements between industry and academic investigators...
Introduction: Registration and publication of trial protocols has become increasingly important and ...
Abstract Background Authors of systematic reviews have difficulty obtaining unpublished data for the...
BACKGROUND AND OBJECTIVE: Prespecification of statistical methods in clinical trial protocols and st...
In 2017, JAMA published a statistical analysis plan (SAP) guidance document for randomised clinical ...
OBJECTIVE: Pre-specification of statistical methods in clinical trial protocols and Statistical Anal...
BACKGROUND: Choosing or altering the planned statistical analysis approach after examination of tria...
Objectives To explore the effectiveness of data sharing by randomized controlled trials (RCTs) in jo...
Background Individual patient data (IPD) meta-analysis is considered the “gold standard” for explori...
Background: All clinical research benefits from transparency and validity. Transparency and validity...
This article is distributed under the terms of the Creative Commons Attribution 4.0 International Li...
Abstract Background Recognizing the value of promotin...
BACKGROUND: Publication of complete trial results is essential if people are to be able to make well...
Evidence of unexplained discrepancies between planned and conducted statistical analyses: a review o...
BACKGROUND: Individual patient data (IPD) meta-analysis is considered the "gold standard" for explor...
Background: Little is known about publication agreements between industry and academic investigators...
Introduction: Registration and publication of trial protocols has become increasingly important and ...
Abstract Background Authors of systematic reviews have difficulty obtaining unpublished data for the...